XAROCEN 200mg/100ml price in UAE

Overview

Welcome to Dwaey, specifically on XAROCEN 200mg/100ml Infusion/Solution for page.
This medicine contains an important and useful components, as it consists of Ciprofloxacin.
XAROCEN 200mg/100ml is available in the market in concentration 2mg/ml and in the form of Infusion/Solution for.

MS PHARMA JORDAN is the producer of XAROCEN 200mg/100ml and it is imported from JORDAN, The most popular alternatives of XAROCEN 200mg/100ml are listed downward .

Mode Of Action

Ciprofloxacin promotes breakage of double-stranded DNA in susceptible organisms and inhibits DNA gyrase, which is essential in reproduction of bacterial DNA.

Indication

Cystic fibrosis
Intra-abdominal infections
Meningitis
Peritonitis
Endocarditis
Anthrax
Otitis media
Septicaemia
Lower Respiratory Tract Infections
Cystitis
Gonorrhoea
Skin and skin structure infections
Nosocomial pneumonia
Urinary tract infections
Enteric fever
Bone and Joint Infections
Biliary tract infections
Surgical Prophylaxis
Gastroenteritis
Q fever
Acute Sinusitis
Cat scratch disease
Spotted fever
Typhus
Chanroid
Brucellosis
Typhoid and paratyphoid fever
Superficial ophthalmic infections
Otitis externa

Precaution

Epilepsy, history of CNS disorders; severe renal or hepatic dysfunction; G6PD deficiency; maintain adequate hydration; myasthaenia gravis. Caution when used in patients with QT prolongation or risk factors e.g. bradycardia, pre-existing cardiac disease or uncorrected electrolyte disturbances. Discontinue treatment if patients experience tendon pain, inflammation or rupture. Avoid usage in methicillin-resistant staphylococcus aureus (MRSA) infections due to high level of resistance. May impair ability to drive or operate machinery. Safety and efficacy have not been established in pregnant and lactating women. Not to be used in children <18 yr; except where benefit clearly exceeds risk. Lactation: Drug enters breast milk; use not recommended (American Academy of Pediatrics Committee states that drug is compatible with nursing)

Side Effects

1-10% Nausea (3%)
Abdominal pain (2%)
Diarrhea (2% adults; 5% children)
Increased aminotransferase levels (2%)
Vomiting (1% adults; 5% children)
Headache (1%)
Increased serum creatinine (1%)
Rash (2%)
Restlessness (1%) <1% Acidosis
Allergic reaction
Angina pectoris
Anorexia
Arthralgia
Ataxia
Back pain
Bad taste
Blurred vision
Breast pain
Bronchospasm
Diplopia
Dizziness
Drowsiness
Dysphagia
Dyspnea
Flushing
Foot pain
Hallucinations
Hiccups
Hypertension
Hypotension
Insomnia
Irritability
Joint stiffness
Lethargy
Migraine
Nephritis
Nightmares
Oral candidiasis
Palpitation
Photosensitivity
Polyuria
Syncope
Tachycardia
Tinnitus
Tremor
Urinary retention
Vaginitis Potentially Fatal: Anaphylactoid reaction; cardiopulmonary arrest.

Contra indication

Hypersensitivity. Not to be used concurrently with tizanidine. Avoid exposure to strong sunlight or sun lamps during treatment.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

May increase plasma concentrations of CYP1A2 substrates (e.g. clozapine, ropinirole, theophylline). Enhances effect of oral anticoagulants (e.g. warfarin) and glibenclamide. Increased toxicity of methotrexate. Plasma concentrations may be increased by probenecid. Reduced absorption w/ oral multivitamins and mineral supplements containing divalent or trivalent cations (e.g. Fe, Zn, Ca) and antacids containing Al, Ca or Mg. Concomitant use w/ class IA antiarrhythmics (e.g. quinidine, procainamide), class III antiarrhythmics (e.g. amiodarone, sotalol), TCAs, macrolides and antipsychotics may result in additive effects on QT interval prolongation. Concurrent use w/ corticosteroids may increase risk of severe tendon disorders. Increased risk of CNS stimulation w/ NSAIDs. Altered serum concentrations of phenytoin. Potentially Fatal: Marked elevation in serum levels of tizanidine which is associated w/ potentiated hypotensive and sedative effect.